SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA classifies Lupin's Somerset facility as ‘Official Action Indicated’

18 Mar 2019 Evaluate

Lupin’s subsidiary -- Novel Laboratories’ Somerset facility has been cautioned by the United States Food and Drug Administration (USFDA) that it may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed.

The US Food and Drug Administration (USFDA) had conducted inspection at Somerset (New Jersey) facility in December 2018, and classified it as Official Action Indicated (OAI). ‘Official Action Indicated’, means approvals of pending applications or supplements from this site maybe withheld.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2264.40 -113.50 (-4.77%)
11-May-2026 15:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.90
Dr. Reddys Lab 1283.30
Cipla 1306.75
Zydus Lifesciences 955.35
Lupin 2264.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×